We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Analysis Links Lung Cancer to Inflammation Aggravated by Smoking

By Biotechdaily staff writers
Posted on 16 Jul 2007
Cancer researchers have found a molecular link that connects lung inflammation to the risk of developing lung cancer especially when the condition is aggravated by heavy smoking.

Investigators at the [U.S.] National Cancer Institute (Bethesda, MD, USA) and the University of Texas M. More...
D. Anderson Cancer Center (Houston, USA) compared differences in genes related to inflammation between more than 1,500 lung cancer patients-more than 80% of them being current or former smokers-and 1,700 controls.

Results published in the July 1, 2007, issue of Cancer Research revealed that among the 59 single nucleotide polymorphisms (SNPs) in 37 inflammation-related genes studied, some variants in the genes for interleukin (IL) 1A and 1B, were found more frequently in patients with lung cancer. These findings were even more apparent among heavy smokers.

Our findings help explain how heavy smoking, for example, combines with a genetic predisposition to create a besieged environment within the lungs, said first author Dr. Eric Engels, a researcher in viral epidemiology at the [U.S.] National Cancer Institute. Essentially, sustained inflammation alters the microenvironment of the lung tissue, damaging cells and altering DNA. While smoking is still the greatest risk factor, we still do not understand how other factors play a role. A better understanding of the risks involving inflammation will lead to a better understanding of cancer prevention.


Related Links:
National Cancer Institute
University of Texas M. D. Anderson Cancer Center

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.